-
Mashup Score: 53Stroke Alert April 2024 - 24 day(s) ago
Negar Asdaghi, MD, MSc Eric D. Goldstein, MD Nastajjia Krementz, MD Dr. Negar Asdaghi: Let’s start with some questions. 1) Is tirofiban a safe replacement for alteplase prior to endovascular treatment? 2) Is there an advantage to performing mechanical thrombectomy via a transradial approach as compared to the traditional transfemoral approach? 3) And finally, who will win the contest between anticoagulation and antiplatelet therapies for treatment of patients with a cervical artery dissection? We’ll
Source: www.ahajournals.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 41Stroke Alert April 2024 - 1 month(s) ago
Negar Asdaghi, MD, MSc Eric D. Goldstein, MD Nastajjia Krementz, MD Dr. Negar Asdaghi: Let’s start with some questions. 1) Is tirofiban a safe replacement for alteplase prior to endovascular treatment? 2) Is there an advantage to performing mechanical thrombectomy via a transradial approach as compared to the traditional transfemoral approach? 3) And finally, who will win the contest between anticoagulation and antiplatelet therapies for treatment of patients with a cervical artery dissection? We’ll
Source: www.ahajournals.orgCategories: General Medicine News, Cardiology News and JournTweet
🧵The April episode of the #StrokeAlert Podcast is now available. In this episode, host @NAsdaghi highlights articles in the April issue of #Stroke and interviews @shadiyaghi2 about the STOP-CAD Study. https://t.co/SydMdVhkQG https://t.co/MrvTukuDh8